Atlas Trials

Study to Assess the Safety and Tolerability of MEDI5117 in Rheumatoid Arthritis Patients

Clinical trial NCT01559103 · TERMINATED

Trial details

NCT number
NCT01559103
Sponsor
Novo Nordisk A/S
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Rheumatoid Arthritis
Start date
2012-05-31
Primary completion
2014-02-28
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.